1. Perälä J, Suvisaari J, Saarni SI, Kuoppasalmi K, Isometsä E, Pirkola S, et al. Lifetime prevalence of psychotic and bipolar i disorders in a general population. Arch Gen Psychiatry 2007;64:19-28. PMID:
17199051.
2. Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 1993;50:85-94. PMID:
8427558.
3. Harrigan SM, McGorry PD, Krstev H. Does treatment delay in first-episode psychosis really matter? Psychol Med 2003;33:97-110. PMID:
12537041.
4. Norman RM, Malla AK. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol Med 2001;31:381-400. PMID:
11305847.
5. McGorry PD, Singh BS. Schizophrenia: risk and possibility of prevention, in Handbook of Studies on Preventive Psychiatry. 1995,Amsterdam: Elsevier Science.
6. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry 2005;39:964-971. PMID:
16343296.
7. Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 2003;29:703-715. PMID:
14989408.
8. Miller TJ, McGlashan TH, Woods SW, Stein K, Driesen N, Corcoran CM, et al. Symptom assessment in schizophrenic prodromal states. Psychiatr Q 1999;70:273-287. PMID:
10587984.
9. McGlashan TH, Miller TJ, Woods SW, Hoffman RE, Davidson L. A scale for the assessment of prodromal symptoms and states. 2001,Dordrecht: Kluwer Academic Publishers.
11. Lemos-Giráldez S, Vallina-Fernández O, Fernández-Iglesias P, Vallejo-Seco G, Fonseca-Pedrero E, Paíno-Piñeiro M, et al. Symptomatic and functional outcome in youth at ultra-high risk for psychosis: a longitudinal study. Schizophr Res 2009;115:121-129. PMID:
19786339.
12. Lemos S, Vallina O, Fernández P, Ortega JA, García P, Gutiérrez A, et al. [Predictive validity of the Scale of Prodromal Symptoms (SOPS)]. Actas Esp Psiquiatr 2006;34:216-223. PMID:
16823681.
13. Yoo SY, Lee KJ, Kang DH, Lee SJ, Ha TH, Wee W, et al. Characteristics of subjects at clinical high risk for schizophrenia: natural follow up study in 'Seoul Youth Clinic'-pilot study. J Korean Neuropsychiatr Assoc 2007;46:19-28.
14. Yi JS, Ahn YM, Shin HK, An SK, Joo YH, Kim SH, et al. Reliability and validity of the Korean version of the Positive and Negative Syndrome Scale. J Korean Neuropsychiatr Assoc 2001;40:1090-1105.
15. First MB, Spitzer RL, Gibbon M, Wiliams JB. Structured Clinical Interview for DSM-IV Axis I Disorders. 1997,New York: Biometrics Research.
16. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 1994,4th edition. Washington, DC: American Psychiatric Association.
17. Andreasen NC, Endicott J, Spitzer RL, Winokur G. The family history method using diagnostic criteria. Reliability and validity. Arch Gen Psychiatry 1977;34:1229-1235. PMID:
911222.
18. Hall RC. Global assessment of functioning. A modified scale. Psychosomatics 1995;36:267-275. PMID:
7638314.
19. McGraw KO, Wong SP. Forming Inferences About Some Intraclass Correlation Coefficients. Psychol Methods 1996;1:30-46.
20. Fleiss JL. Analysis of data from multiclinic trials. Control Clin Trials 1986;7:267-275. PMID:
3802849.
21. Nunnally JC, Bernstein IH. Psychometric theory. 1994,New York: McGraw-Hill.
22. Cattell RB. The scree test for the number of factors. Multivariate Behav Res 1996;1:245-276.
23. Gorsuch RL. Factor Analysis. 1983,Hillsdale: Lawrence Erlbaum Associates.
24. Muthen LK, Muthen BO. How to use a Monte Carlo study to decide on sample size and determine power. Struct Equ Modeling 2002;9:599-620.
25. Thurstone LL. Multiple-factor analysis. 1947,Chicago, IL: Chicago Press.
26. Lindenmayer JP, Grochowski S, Hyman RB. Five factor model of schizophrenia: replication across samples. Schizophr Res 1995;14:229-234. PMID:
7766534.
27. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, et al. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res 2003;60:21-32. PMID:
12505135.
29. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 2008;65:28-37. PMID:
18180426.
30. Peralta V, Cuesta MJ. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res 1994;53:31-40. PMID:
7991730.
31. von Knorring L, Lindström E. The Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Construct validity and interrater reliability. Acta Psychiatr Scand 1992;86:463-468. PMID:
1281960.
32. Hawkins KA, McGlashan TH, Quinlan D, Miller TJ, Perkins DO, Zipursky RB, et al. Factorial structure of the Scale of Prodromal Symptoms. Schizophr Res 2004;68:339-347. PMID:
15099615.
33. Kawasaki Y, Maeda Y, Sakai N, Higashima M, Urata K, Yamaguchi N, et al. Evaluation and interpretation of symptom structures in patients with schizophrenia. Acta Psychiatr Scand 1994;89:399-404. PMID:
8085470.
34. Lindenmayer JP, Bernstein-Hyman R, Grochowski S, Bark N. Psychopathology of Schizophrenia: initial validation of a 5-factor model. Psychopathology 1995;28:22-31. PMID:
7871117.
35. Lancon C, Auquier P, Nayt G, Reine G. Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS). Schizophr Res 2000;42:231-239. PMID:
10785581.